ENA713
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Alzheimer's Dementia
Conditions
Alzheimer's Dementia
Trial Timeline
Aug 1, 2012 → Jun 1, 2015
NCT ID
NCT01585272About ENA713
ENA713 is a approved stage product being developed by Novartis for Alzheimer's Dementia. The current trial status is completed. This product is registered under clinical trial identifier NCT01585272. Target conditions include Alzheimer's Dementia.
What happened to similar drugs?
20 of 20 similar drugs in Alzheimer's Dementia were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01948791 | Approved | Completed |
| NCT01585272 | Approved | Completed |
Competing Products
20 competing products in Alzheimer's Dementia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| LY450139 + Placebo | Eli Lilly | Phase 3 | 40 |
| Solanezumab + Placebo | Eli Lilly | Phase 3 | 32 |
| LY450139 dihydrate + placebo | Eli Lilly | Phase 2 | 35 |
| GSK4527226 | Alector | Phase 2 | 29 |
| GSK4527226 | Alector | Phase 2 | 32 |
| AL002 | Alector | Phase 2 | 17 |
| Solanezumab + Placebo | Eli Lilly | Phase 3 | 32 |
| simufilam | Cassava Sciences | Phase 2 | 17 |
| Remternetug + Placebo | Eli Lilly | Phase 3 | 44 |
| solanezumab | Eli Lilly | Phase 2 | 35 |
| LY2886721 + Placebo | Eli Lilly | Phase 1 | 29 |
| Gantenerumab + Gantenerumab + Gantenerumab + Placebo | Chugai Pharmaceutical | Phase 1 | 29 |
| Alfoatirin® Tab. + Aripezil® Tab. + Aripezil® Tab. | Yuhan | Approved | 39 |
| FK962 | Astellas Pharma | Phase 2 | 27 |
| ASP0777 + Placebo | Astellas Pharma | Phase 1 | 29 |
| Elenbecestat + Placebo | Eisai | Phase 3 | 32 |
| Donepezil | Eisai | Approved | 43 |
| Aricept (donepezil SR 23 mg) + Aricept (donepezil IR 10 mg) | Eisai | Phase 3 | 40 |
| Donepezil hydrochloride | Eisai | Phase 3 | 40 |
| Donepezil Hydrochloride | Eisai | Pre-clinical | 26 |